ArticleOncotarget2018

Targeting the mevalonate pathway is a novel therapeutic approach to inhibit oncogenic FoxM1 transcription factor in human hepatocellular carcinoma.

Satoshi Ogura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.